Is there a relationship between islet cell surface antibodies and clinical, biochemical, hormonal, and immunogenetic parameters in newly diagnosed type I diabetics?
作者信息
Michaelis D, Rjasanowski I, Ratzmann K P, Strese J, Dietz H, Hildmann W
出版信息
Acta Biol Med Ger. 1982;41(12):1093-8.
PMID:6765149
Abstract
摘要
相似文献
1
2
3
Validity of WHO criteria for classification of newly diagnosed diabetics.世界卫生组织新诊断糖尿病分类标准的有效性。
Exp Clin Endocrinol. 1985 Feb;85(1):61-9. doi: 10.1055/s-0029-1210420.
4
[Clinical significance of islet cell antibody and islet cell surface antibody in diabetics].[胰岛细胞抗体和胰岛细胞表面抗体在糖尿病患者中的临床意义]
Nihon Rinsho. 1990 Dec;48 Suppl:300-7.
5
A population survey of pancreatic islet cell antibodies.胰岛细胞抗体的人群调查。
Clin Exp Immunol. 1980 Jan;39(1):125-9.
6
[HLA and type-1 diabetes: a prospective study of all new cases diagnosed in Piedmont in one year].
Pathologica. 1983;75 Suppl:40-50.
7
Islet cell antibodies and diabetes in Nigerians.尼日利亚人的胰岛细胞抗体与糖尿病
Trop Geogr Med. 1981 Jun;33(2):161-4.
8
[Detection of antibodies against pancreatic islet cells in clinical practice].[临床实践中胰岛细胞抗体的检测]
Orv Hetil. 1999 Nov 28;140(48):2695-701.
9
引用本文的文献
1
Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma.ICAM1 的失活抑制了尤文肉瘤的转移并改善了预后。
J Cancer Res Clin Oncol. 2021 Feb;147(2):393-401. doi: 10.1007/s00432-020-03431-3. Epub 2020 Oct 26.
Zotero 插件